Phio Pharmaceuticals Corp

PHIO · NASDAQ · Healthcare / Biotechnology

0.771USD-0.04 (-5.03%)

Price History

Full chart

Market Stats

Previous Close0.8118

Open0.8062

Day Range0.75 – 0.8399

52-Week Range0.8127 – 2.48

Volume63.05K

Market Cap11.73M

P/E (TTM)0.00

Forward P/E0.31

EPS-1.29

Dividend Yield0.00%

Beta0.80

50-Day Avg1.07

200-Day Avg1.11

About

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Robert J. Bitterman
Employees6
Headquarters411 Swedeland Road, King of Prussia, PA, United States, 19406, USA
Websitehttps://phiopharma.com

Leadership

Mr. Robert J. BittermanPresident, CEO & Chairman · b. 1951
Ms. Lisa C. CarsonCFO, Principal Accounting Officer and VP of Finance & Administration · b. 1966
Ms. Linda M. MahoneySenior Vice President of Development
Dr. Jennifer Phillips Pharm.D.Senior Vice President of Regulatory & Corporate Affairs

Financials

Income Statement

Currency: USD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	97.00K	399.00K	71.00K	34.00K	19.00K	15.00K	138.00K	21.00K	4.36K	0	0	0	0	0
Growth (%)	-	-	+311.34%	-82.21%	-52.11%	-44.12%	-21.05%	+820.00%	-84.78%	-79.23%	-100.00%	-	-	-	-
Cost of Revenue	-	12.97M	17.65M	5.68M	6.92M	5.42M	5.37M	4.33M	4.30M	3.72M	192.00K	193.00K	6.33M	3.64M	4.62M
Gross Profit	-	-12.88M	-17.25M	-5.61M	-6.89M	-5.40M	-5.36M	138.00K	21.00K	-3.72M	-192.00K	-193.00K	-6.33M	-3.64M	-4.62M
Gross Margin	-	-13276.29%	-4323.81%	-7900.00%	-20267.65%	-28400.00%	-35700.00%	100.00%	100.00%	-85190.28%	-	-	-	-	-
Operating Expense	-	97.00K	3.70M	3.22M	3.35M	3.62M	8.71M	7.50M	9.01M	5.08M	13.32M	11.27M	4.49M	3.74M	4.60M
Operating Income	-12.77M	-12.97M	-20.95M	-8.83M	-10.24M	-9.02M	-14.06M	-7.36M	-8.99M	-8.79M	-13.51M	-11.46M	-10.82M	-7.39M	-9.22M
Operating Margin	-	-13376.29%	-5250.38%	-12430.99%	-30108.82%	-47447.37%	-93746.67%	-5336.23%	-42795.24%	-201581.84%	-	-	-	-	-
EBITDA	-15.16M	-12.70M	-20.85M	-8.74M	-10.16M	-8.96M	-14.00M	-7.28M	-8.92M	-8.72M	-13.44M	-11.27M	-10.64M	-7.15M	-8.70M
EBITDA Margin	-	-13095.88%	-5225.56%	-12308.45%	-29882.35%	-47168.42%	-93353.33%	-5277.54%	-42476.19%	-199931.22%	-	-	-	-	-
Net Income	-10.22M	-12.88M	-20.93M	-8.80M	-10.22M	-8.99M	-12.45M	-7.36M	-8.84M	-8.79M	-13.21M	-11.30M	-10.83M	-7.15M	-8.70M
Net Income Margin	-	-13278.35%	-5244.36%	-12394.37%	-30067.65%	-47336.84%	-83013.33%	-5333.33%	-42100.00%	-201604.77%	-	-	-	-	-
R&D	6.62M	10.45M	17.65M	5.68M	6.92M	5.42M	5.37M	4.33M	4.30M	3.72M	8.89M	7.01M	6.33M	3.64M	4.62M
R&D as % of Total Revenue	-	10774.23%	4423.81%	8000.00%	20367.65%	28500.00%	35800.00%	3134.78%	20476.19%	85190.28%	-	-	-	-	-
Interest Expense	0	30.00K	24.00K	0	0	0	1.00K	0	0	0	9.00K	175.00K	-	231.00K	-
Interest Expense % of Total Revenue	-	30.93%	6.02%	0.00%	0.00%	0.00%	6.67%	0.00%	0.00%	0.00%	-	-	-	-	-

Balance Sheet

Currency: USD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.69M	5.59M	14.94M	9.19M	11.16M	13.40M	4.10M	15.32M	8.04M	15.74M	25.17M	12.81M	9.36M	5.74M	21.49M
Total Liabilities	2.28M	11.43M	10.00M	6.44M	2.27M	2.54M	2.27M	1.74M	2.29M	2.72M	3.24M	1.97M	1.63M	1.01M	1.34M
Total Equity	-587.00K	-5.84M	4.94M	2.75M	8.89M	10.86M	1.83M	13.58M	5.75M	13.02M	21.93M	10.84M	7.73M	4.72M	20.15M
Cash	503.00K	5.13M	11.39M	8.50M	5.12M	12.91M	3.58M	14.88M	6.93M	14.24M	24.06M	11.78M	8.49M	5.38M	21.03M
Total Debt	534.00K	5.00K	-	-	-	-	-	-	518.00K	642.00K	295.00K	170.00K	35.00K	-	-
Net Debt	31.00K	-5.12M	-11.39M	-8.50M	-5.12M	-12.91M	-3.58M	-14.88M	-6.42M	-13.60M	-23.76M	-11.61M	-8.46M	-5.38M	-21.03M

Cash Flow

Currency: USD	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-9.99M	-5.06M	-6.31M	-7.76M	-7.32M	-7.76M	-9.51M	-7.52M	-8.64M	-8.80M	-11.86M	-12.13M	-10.75M	-7.11M	-7.98M
Investing Cash Flow	-112.00K	16.00K	-3.09M	2.92M	-5.56M	5.35M	-103.00K	-5.00K	-72.00K	-19.00K	-51.00K	-121.00K	-5.00K	8.00K	-12.00K
Financing Cash Flow	3.71M	9.67M	15.67M	1.95M	9.49M	10.20M	292.00K	18.82M	772.00K	16.13M	21.72M	-26.00K	7.41M	4.00M	23.64M
Capital Expenditure	59.00K	15.00K	78.00K	95.00K	57.00K	4.00K	203.00K	5.00K	72.00K	19.00K	51.00K	121.00K	5.00K	1.00K	12.00K
Free Cash Flow	-10.05M	-5.08M	-6.39M	-7.85M	-7.37M	-7.76M	-9.72M	-7.53M	-8.72M	-8.82M	-11.91M	-12.25M	-10.75M	-7.11M	-7.99M
Dividends Paid	-	-	12.00K	4.13M	209.00K	-	-	-	1.00K	4.09M	-	-	-	-	-
FCF to OCF	100.59%	100.30%	101.24%	101.22%	100.78%	100.05%	102.13%	100.07%	100.83%	100.22%	100.43%	101.00%	100.05%	100.01%	100.15%
Dividend Paid to FCF	-	-	-0.19%	-52.59%	-2.83%	-	-	-	-0.01%	-46.33%	-	-	-	-	-

Earnings

Report Date	Jun 30, 2012	Nov 28, 2012	Feb 27, 2013	May 15, 2013	Aug 14, 2013	Nov 14, 2013	Mar 28, 2014	May 14, 2014	Aug 14, 2014	Nov 13, 2014	Mar 30, 2015	May 13, 2015	Aug 12, 2015	Nov 12, 2015	Mar 30, 2016	May 13, 2016	Aug 11, 2016	Nov 10, 2016	Mar 30, 2017	May 11, 2017	Aug 10, 2017	Nov 8, 2017	Mar 26, 2018	May 10, 2018	Aug 14, 2018	Nov 14, 2018	Mar 27, 2019	May 14, 2019	Aug 12, 2019	Nov 12, 2019	Mar 26, 2020	May 12, 2020	Aug 12, 2020	Nov 10, 2020	Mar 25, 2021	May 13, 2021	Aug 12, 2021	Nov 10, 2021	Mar 22, 2022	May 12, 2022	Aug 11, 2022	Nov 10, 2022	Mar 22, 2023	May 11, 2023	Aug 10, 2023	Nov 9, 2023	Mar 20, 2024	Apr 1, 2024	Aug 14, 2024	Nov 14, 2024	Mar 31, 2025	May 15, 2025	Aug 14, 2025	Nov 13, 2025	Mar 6, 2026	May 7, 2026	Aug 13, 2026	Nov 12, 2026
EPS Estimate	-	-	-	-	-190080.29	-201960.30	-20460.00	-184140.28	-100980.15	-112860.17	-9240.00	-59400.09	-41580.06	-23760.04	-26730.04	-2970.00	-21384.03	-19008.03	-1518.00	-6534.01	-6534.01	-6534.01	-5702.41	-	-3504.61	-2643.30	-72.60	-475.20	-475.20	-475.20	-475.20	-	-69.66	-40.50	-45.36	-	-28.08	-27.00	-3.84	-32.40	-33.48	38.88	-29.16	-	-	-12.87	-1.30	-11.70	-4.59	-4.14	-1.23	-	-0.36	-0.44	-0.47	-0.23	-0.36	-0.36
EPS Actual	-1000000.00	-331215.19	-295371.21	-1000000.00	-231660.35	-178200.27	55440.00	-190080.29	-136620.20	-100980.15	-8580.00	-77220.12	-29700.04	-23760.04	-23760.04	-2244.00	-20196.03	-20196.03	-3960.00	-7128.01	-6444.91	-6534.01	-4989.61	-49.23	-2732.40	-2019.60	-66.00	-594.00	-475.20	-475.20	-543.24	-1.33	-36.72	-43.20	-44.28	-0.32	-21.60	-30.24	-3.24	-20.52	-20.52	-28.08	-21.78	-3.15	-1.47	-10.26	-0.85	-1.53	-3.62	-1.54	-0.85	-0.41	-0.45	-0.44	-0.15	-0.34	-0.36	-
Surprise	-	-	-	-	-21.88%	11.76%	370.97%	-3.23%	-35.29%	10.53%	7.14%	-30.00%	28.57%	0.00%	11.11%	24.44%	5.56%	-6.25%	-160.87%	-9.09%	1.36%	0.00%	12.50%	-	22.03%	23.60%	9.09%	-25.00%	0.00%	0.00%	-14.32%	-	47.29%	-6.67%	2.38%	-	23.08%	-12.00%	15.63%	36.67%	38.71%	-172.22%	25.31%	-	-	20.28%	34.62%	86.92%	21.13%	62.80%	30.89%	-	-25.00%	0.00%	68.09%	-47.83%	0.00%	-
Timing	-	-	-	-	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	-	After-hours	After-hours	-	After-hours	-	-

Key Statistics & Ratios

Market Cap11.73M

Enterprise Value-1.15M

Trailing P/E0.00

Forward P/E0.31

Price / Sales48.01

Price / Book0.94

EPS-1.29

Book Value1.09

Revenue (TTM)0

Gross Profit (TTM)-8.53M

EBITDA-13.47M

Profit Margin0.00%

Operating Margin0.00%

Return on Equity-113.71%

Return on Assets-65.77%

Shares Outstanding11.62M

Shares Float11.22M

Beta0.80

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Buy

Based on 1 analystsTarget 14.00

Buy
1

Ownership Breakdown

Institutions: 10.21%
Insiders: 3.35%
Retail / Other: 86.44%

Top Institutional Holders

Geode Capital Management, LLC
147.25K1.27%
Jane Street Group LLC
119.19K1.03%
Vanguard Capital Management, LLC
79.85K0.69%
Citadel Advisors Llc
47.15K0.41%
Cetera Investment Advisers
45.00K0.39%
Vanguard Fiduciary Trust Co
38.17K0.33%
HRT FINANCIAL LLC
34.73K0.30%
Scientech Research LLC
30.03K0.26%
UBS Group AG
26.99K0.23%
XTX Topco Ltd
24.87K0.21%
Northern Trust Corp
23.76K0.20%
Two Sigma Investments LLC
21.50K0.19%
TWO SIGMA SECURITIES, LLC
15.22K0.13%
CapTrust Financial Advisors
10.00K0.09%
Tower Research Capital LLC
7.62K0.07%

Top Fund Holders

Fidelity Extended Market Index
61.36K0.53%
Nomura Healthcare Fund Class I
50.00K0.43%
Fidelity Series Total Market Index
14.66K0.13%
Fidelity Total Market Index
13.29K0.11%
Bridgeway Ultra-Small Company
12.00K0.10%

Stock Splits

Jul 5, 20241:9
Jan 26, 20231:12
Jan 15, 20201:55
Jan 8, 20181:10
Apr 18, 20161:10
Jul 24, 20131:30